Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 4711 AL 4725

Myoclonus: an update

Thomas B, Frucht SJ.

Curr Opin Neurol. 2024 Aug 1;37(4):421-425. doi: 10.1097/WCO.0000000000001276. Epub 2024 May 24.

Non-coding RNAs and neuroinflammation: implications for neurological disorders

Chen Y, Mateski J, Gerace L, Wheeler J, Burl J, Prakash B, Svedin C, Amrick R, Adams BD.

Exp Biol Med (Maywood). 2024 Feb 28;249:10120. doi: 10.3389/ebm.2024.10120. eCollection 2024.

The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions

Kerkis I, da Silva ÁP, Araldi RP.

Front Immunol. 2024 Jun 24;15:1400533. doi: 10.3389/fimmu.2024.1400533. eCollection 2024.

Case report: Treatment of Wilson's disease by human amniotic fluid administration

Liang L, Xin H, Shen X, Xu Y, Zhang L, Liu D, Zhao L, Tong X.

Front Med (Lausanne). 2024 Feb 14;11:1297457. doi: 10.3389/fmed.2024.1297457. eCollection 2024.

Dysfunctional mitochondria in age-related neurodegeneration: Utility of melatonin as an antioxidant treatment

Reiter RJ, Sharma RN, Manucha W, Rosales-Corral S, Almieda Chuffa LG, Loh D, Luchetti F, Balduini W, Govitrapong P.

Ageing Res Rev. 2024 Nov;101:102480. doi: 10.1016/j.arr.2024.102480. Epub 2024 Sep 3.

Biomarker-based human and animal sperm phenotyping: the good, the bad and the ugly†

Sutovsky P, Hamilton LE, Zigo M, Ortiz D'Avila Assumpção ME, Jones A, Tirpak F, Agca Y, Kerns K, Sutovsky M.

Biol Reprod. 2024 Jun 12;110(6):1135-1156. doi: 10.1093/biolre/ioae061.

Molecular Mechanisms in the Design of Novel Targeted Therapies for Neurodegenerative Diseases

Nowak I, Paździor M, Sarna R, Madej M.

Curr Issues Mol Biol. 2024 May 29;46(6):5436-5453. doi: 10.3390/cimb46060325.

Immunology of cell and gene therapy approaches for neurologic diseases

Widner H.

Handb Clin Neurol. 2024;205:135-144. doi: 10.1016/B978-0-323-90120-8.00018-6.

"A patent review on arachidonic acid lipoxygenase (LOX) inhibitors for the treatment of neurodegenerative diseases (2018-present)"

Vergini DE, Hadjipavlou-Litina D.

Expert Opin Ther Pat. 2024 Dec 27:1-14. doi: 10.1080/13543776.2024.2447067. Online ahead of print.

Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation

Desouky MA, Michel HE, Elsherbiny DA, George MY.

Life Sci. 2024 Dec 15;359:123206. doi: 10.1016/j.lfs.2024.123206. Epub 2024 Nov 1.

Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review

Rezaei A, Moqadami A, Khalaj-Kondori M.

Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2835-2848. doi: 10.1007/s00210-023-02839-1. Epub 2023 Nov 22.

CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders

Chrzanowski S, Batra R.

Pediatr Neurol. 2024 Apr;153:166-174. doi: 10.1016/j.pediatrneurol.2024.01.021. Epub 2024 Feb 1.

PDE10A Mutation as an Emerging Cause of Childhood-Onset Hyperkinetic Movement Disorders: A Review of All Published Cases

Kalampokini S, Xiromerisiou G, Bargiotas P, Anastasiadou VC, Costeas P, Hadjigeorgiou GM.

Neuropediatrics. 2024 Aug;55(4):217-223. doi: 10.1055/a-2281-1822. Epub 2024 Mar 5.

Clinical and neuroimaging characteristics of diabetic striatopathy: a case series report

Chen Y, Wu C, Ren M, Wang Q, Wang Z, Zhang Y, Yu Y.

Front Endocrinol (Lausanne). 2024 Dec 10;15:1429026. doi: 10.3389/fendo.2024.1429026. eCollection 2024.

Sequencing and characterizing short tandem repeats in the human genome

Tanudisastro HA, Deveson IW, Dashnow H, MacArthur DG.

Nat Rev Genet. 2024 Jul;25(7):460-475. doi: 10.1038/s41576-024-00692-3. Epub 2024 Feb 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias